Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: Impact on patient management

Acta Dermato-Venereologica

Volumn 93, Issue 4, 2013, Pages 411-416

  Eriksson, Hanna ^a   Frohm Nilsson, Margareta ^a   Hedbled, Mari Anne ^a   Hellborg, Henrik ^a   Kanter Lewensohn, Lena ^a   Krawiec, Kamilla ^a   Rozell, Barbro Lundh ^a,b   Månsson Brahme, Eva ^a   Hansson, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Interobserver; Melanoma; Pathology; Prognosis; Treatment; Variability

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL PRACTICE; CONTROLLED STUDY; CUTANEOUS MELANOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOLOGIST; PATIENT CARE; PRIMARY TUMOR; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; ULCER;

CLINICAL COMPETENCE; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SKIN ULCER; SWEDEN; TUMOR BURDEN;

EID: 84879714838     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1517     Document Type: Article

References (29)

1. Eggermont AM, Suciu S, Testori A, Kruit WH, Marsden J, Punt CJ, et al. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 2011; 48: 218-225
2. Masback A, Olsson H, Westerdahl J, Ingvar C, Jonsson N. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 2001; 11: 435-445
3. Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Moller T, et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004; 101: 2067-2078
4. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634
5. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206
6. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. [Research Support, Non-US Gov't]. 1994; 86: 761-769
7. Prade M, Sancho-Garnier H, Cesarini JP, Cochran A. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980; 26: 159-163
8. Holman CD, James IR, Heenan PJ, Matz LR, Blackwell JB, Kelsall GR, et al. An improved method of analysis of observer variation between pathologists. Histopathology 1982; 6: 581-589
9. Heenan PJ, Matz LR, Blackwell JB, Kelsall GR, Singh A, ten Seldam RE, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 1984; 8: 717-729
10. Colloby PS, West KP, Fletcher A. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol 1991; 163: 245-250
11. Krieger N, Hiatt RA, Sagebiel RW, Clark WH Jr, Mihm MC Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma: effects upon an analytic study. J Clin Epidemiology 1994; 47: 897-902
12. Lock-Andersen J, Hou-Jensen K, Hansen JP, Jensen NK, Sogaard H, Andersen PK. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 1995; 29: 141-148
13. Corona R, Mele A, Amini M, De Rosa G, Coppola G, Piccardi P, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218-1223
14. Brochez L, Verhaeghe E, Grosshans E, Haneke E, Pierard G, Ruiter D, et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002; 196: 459-466
15. Scolyer RA, Shaw HM, Thompson JF, Li LX, Colman MH, Lo SK, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 2003; 27: 1571-1576
16. Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg 2009; 249: 641-647
17. Larsen TE, Little JH, Orell SR, Prade M. International pathologists congruence survey on quantitation of malignant melanoma. Pathology 1980; 12: 245-253
18. Suffin SC, Waisman J, Clark WH, Jr, Morton DL. Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer 1977; 40: 3112-3114
19. Hansson J. The Swedish Melanoma Study Group - a brief history. Arch Oncol 2005; 13 Suppl 1: 72-74
20. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648
21. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27-33
22. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908
23. Clark WH, Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-727
24. Arrington JH, 3rd, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131-143
25. Santillan AA, Messina JL, Marzban SS, Crespo G, Sondak VK, Zager JS. Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. J Clin Oncol 2010; 28: 481-486
26. Ruiter DJ, Spatz A, van den Oord JJ, et al. Pathologic staging of melanoma. Semin Oncol 2002; 29: 370-381
27. Jovanovic B, Krockel D, Linden D, Nilsson B, Egyhazi S, Hansson J. Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma. J Invest Dermatol 2008; 128: 2696-2704
28. Shoo BA, Sagebiel RW, Kashani-Sabet M. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol 2010; 62: 751-756
29. [National quality registry for skin melanoma. Years of diagnosis 1990-2008]. http://www.lio.se/pages/26092/ Melanom_NatKvalReg1990-2008.pdf (in Swedish).